| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.042 | 0.9 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.9 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.9 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |